Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Guilford (GLFD) - Steadily Rising -- Ignore unavailable to you. Want to Upgrade?

To: Russian Bear who wrote (130)	10/22/1997 5:06:00 PM
From: tdinovo	Read Replies (1) \| Respond to of 496

RB, I read Amgen's report and came to the same conclusion, although its also clear they have a lot of other activities to spend money on. Not the least is the $1 billion stock buy-back! Frankly, I'm a little concerned about that since that also is the amount of cash they have on hand. Amgen's cash flow from operations help mitigate this to some extent but if the stock really comes unglued tomorrow, they may need to spend the money quickly. Ted